SIG
69
17
RF
53
2
DNB
56
8
WHR
48
4
DGX
54
-7
ISRG
59
3
AZO
63
10
CRM
37
2
NRG
64
5
FE
60
-2
V
48
4
MCO
65
3
K
54
-2
HBI
62
3
RRC
72
3
ECL
52
-2
GIS
52
-5
UAL
51
6
XOM
62
5
PBI
53
14
SIG
69
17
RF
53
2
DNB
56
8
WHR
48
4
DGX
54
-7
ISRG
59
3
AZO
63
10
CRM
37
2
NRG
64
5
FE
60
-2
V
48
4
MCO
65
3
K
54
-2
HBI
62
3
RRC
72
3
ECL
52
-2
GIS
52
-5
UAL
51
6
XOM
62
5
PBI
53
14
Financhill
Back

Vanda Pharmaceuticals 10K Form

Sell
37

VNDA
Vanda Pharmaceuticals

Last Price:
$4.92
Seasonality Move:
92.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q VNDA/Vanda Pharmaceuticals Quarterly
2023-11-09 10Q VNDA/Vanda Pharmaceuticals Quarterly
2023-07-28 10Q VNDA/Vanda Pharmaceuticals Quarterly
2023-05-03 10Q VNDA/Vanda Pharmaceuticals Quarterly
2022-11-03 10Q VNDA/Vanda Pharmaceuticals Quarterly
2022-08-04 10Q VNDA/Vanda Pharmaceuticals Quarterly

Receive VNDA News And Ratings

See the #1 stock for the next 7 days that we like better than VNDA

VNDA Financial Statistics

Sales & Book Value

Annual Sales: $198.8M
Cash Flow: $-2M
Price / Cash Flow: 0
Annual Sales: $9.24
Price / Book: 0.53

Profitability

EPS (TTM): -0.32000
Net Income (TTM): $-18.9M
Gross Margin: $187.5M
Return on Equity: -3.49%
Return on Assets: -2.9%

Vanda Pharmaceuticals Earnings Forecast

Key Vanda Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for VNDA is 94.31%.
  • The Selling, General & Administrative Expenses for VNDA have been equal to 73.66% of Gross Profit Margin.
  • The Research & Development expenses have been 37.45% of Revenue.
  • The Net Earning history of VNDA is -9.51% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 11 years.

Vanda Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VNDA
CUSIP: 921659
Website: vandapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.39
Quick Ratio: 4.22

Price-to-Earnings

Trailing P/E Ratio: 110.5
Forward P/E Ratio: 0

VNDA Technical Analysis vs Fundamental Analysis

Sell
37
Vanda Pharmaceuticals (VNDA) is a Sell

Is Vanda Pharmaceuticals a Buy or a Sell?